COMP <GO>
ECG vs IBP // RSI-14 & 200D SMA MOMENTUM
Everus Construction Group Inc. (NYSE) VS. Installed Building Products Inc. (NYSE) • 15-METRIC TALLY: ECG 5
— IBP 8
▲ RSI-14 & 200D SMA MOMENTUM LEADER: IBP
LAST: $108.06 (+2.14%) • MKT CAP: $5.52B
rsi-technicals
47.4
LAST: $212.23 (+6.17%) • MKT CAP: $5.64B
rsi-technicals
61.0
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ECG VS. IBP)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ECG | IBP | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 12.10% | 34.00% | -21.90 | IBP | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 30.40% | 24.70% | +5.70 | ECG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 13.7x | 13.8x | -0.10 | ECG | /valuation <GO> |
| Free Cash Flow Yield | -0.21% | 5.33% | -5.54 | IBP | /fcf-yield <GO> |
| Operating Margin | 7.10% | 13.00% | -5.90 | IBP | /operating-margins <GO> |
| Net Profit Margin | 5.40% | 8.90% | -3.50 | IBP | /net-margins <GO> |
| Revenue Growth (YoY) | 31.50% | 1.00% | +30.50 | ECG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.55% | -1.55 | IBP | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.47 | 5.66 | +0.81 | ECG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 6/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 47.4 | 61.0 | -13.60 | IBP | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.13 | 1.05 | +0.08 | ECG | /macro-sensitivity <GO> |
| Forward P/E Multiple | 22.9x | 19.8x | +3.10 | IBP | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.52B | $5.64B | -$122.9M | IBP | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ECG REV | IBP REV | ECG GROSS % | IBP GROSS % | ECG FCF | IBP FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.75B | $2.97B | 12.1% | 34.0% | -$11.7M | $300.8M |
| FY 2024 | $2.85B | $2.94B | 11.9% | 33.8% | $35.1M | $251.4M |
| FY 2023 | $2.85B | $2.78B | — | — | $42.9M | $215.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ECG // BETA 1.13
IBP // BETA 1.05